U.S. Dried Blood Spot Collection Cards Market Size, Share & Trends Analysis Report By Application (New Born Screening (NBS), Forensics), By Card Type (Whatman 903, FTA), By End-use, By Country, And Segment Forecasts, 2024 - 2030
This report can be delivered to the clients within 3 Business Days
U.S. Dried Blood Spot Collection Cards Market Growth & Trends
The U.S. dried blood spot collection cards market size is anticipated to reach USD 149.9 million by 2030, growing at a CAGR of 3.9% during the forecast period, according to a new report by Grand View Research, Inc. The rising application in newborn screening and expanding utilization of DBS cards in forensic toxicology are significant factors contributing to the market growth. According to the U.S. Department of Health & Human Services (HSS) and Health Resources & Services Administration (HRSA), each state of the U.S. possesses its legal list of requirements for screening newborns.
The growing adoption of dried blood spot collection cards in forensic toxicology and their increasing use in newborn screening is expanding the scope of these valuable diagnostic tools. These cards offer several advantages, such as ease of sample collection, storage stability, and cost-effectiveness. In forensic toxicology, DBS cards enable efficient detection of various substances, including drugs, alcohol, and toxins, in individuals. This information is crucial for determining the cause of death and identifying potential criminals.
In newborn screening, DBS cards facilitate early detection of genetic disorders and metabolic diseases, allowing for timely interventions and improved health outcomes for infants. As research progresses and analytical techniques continue to advance, the utilization of DBS cards in these fields is expected to expand further, benefiting forensic investigations and newborn healthcare, and contributing to the market.
U.S. Dried Blood Spot Collection Cards Market Report Highlights
U.S. Dried Blood Spot Collection Cards Market Growth & Trends
The U.S. dried blood spot collection cards market size is anticipated to reach USD 149.9 million by 2030, growing at a CAGR of 3.9% during the forecast period, according to a new report by Grand View Research, Inc. The rising application in newborn screening and expanding utilization of DBS cards in forensic toxicology are significant factors contributing to the market growth. According to the U.S. Department of Health & Human Services (HSS) and Health Resources & Services Administration (HRSA), each state of the U.S. possesses its legal list of requirements for screening newborns.
The growing adoption of dried blood spot collection cards in forensic toxicology and their increasing use in newborn screening is expanding the scope of these valuable diagnostic tools. These cards offer several advantages, such as ease of sample collection, storage stability, and cost-effectiveness. In forensic toxicology, DBS cards enable efficient detection of various substances, including drugs, alcohol, and toxins, in individuals. This information is crucial for determining the cause of death and identifying potential criminals.
In newborn screening, DBS cards facilitate early detection of genetic disorders and metabolic diseases, allowing for timely interventions and improved health outcomes for infants. As research progresses and analytical techniques continue to advance, the utilization of DBS cards in these fields is expected to expand further, benefiting forensic investigations and newborn healthcare, and contributing to the market.
U.S. Dried Blood Spot Collection Cards Market Report Highlights
- Based on application, the newborn screening segment held the largest revenue share of 23.19% in 2023 and is expected to grow at a significant CAGR of 3.3% during the forecast period. The growth is attributed to the larger number of newborn screenings in the U.S.
- Based in card type, the Whatman 903 segment dominated the market with the largest revenue share of 32.33% in 2023 and is expected to grow at the fastest CAGR throughout the forecast period
- Based on end-use, the hospitals & clinics segment accounted for the largest revenue share in 2023. The segment is expected to exhibit a lucrative CAGR over the forecast period
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Application
1.2.2. Card Type
1.2.3. End-use
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Volume price analysis (Model 2)
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Application outlook
2.2.2. Card Type outlook
2.2.3. End-use outlook
2.3. Competitive Insights
CHAPTER 3. U.S. DRIED BLOOD SPOT COLLECTION CARDS MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. U.S. Dried Blood Spot Collection Cards Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
CHAPTER 4. U.S. DRIED BLOOD SPOT COLLECTION CARDS MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
4.1. Application Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. U.S. Dried Blood Spot Collection Cards Market by Application Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4.1. Newborn Screening (NBS)
4.4.1.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.4.2. Infectious Diseases Testing
4.4.2.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.4.3. Therapeutic Drug Monitoring
4.4.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.4.4. Forensics
4.4.4.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.4.5. CRO/Research
4.4.5.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.4.6. Other Applications
4.4.6.1. Market estimates and forecasts 2018 - 2030 (USD Million)
CHAPTER 5. U.S. DRIED BLOOD SPOT COLLECTION CARDS MARKET: CARD TYPE ESTIMATES & TREND ANALYSIS
5.1. Card Type Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. U.S. Dried Blood Spot Collection Cards Market by Card Type Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4.1. Whatman
5.4.1.1. Market estimates and forecasts 2018 - 2030 (USD Million)
5.4.2. Ahlstrom
5.4.2.1. Market estimates and forecasts 2018 - 2030 (USD Million)
5.4.3. FTA
5.4.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)
5.4.4. Others
5.4.4.1. Market estimates and forecasts 2018 - 2030 (USD Million)
CHAPTER 6. U.S. DRIED BLOOD SPOT COLLECTION CARDS MARKET: END-USE ESTIMATES & TREND ANALYSIS
6.1. End-use Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. U.S. Dried Blood Spot Collection Cards Market by End-use Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.4.1. Hospitals & Clinics
6.4.1.1. Market estimates and forecasts 2018 - 2030 (USD Million)
6.4.2. Diagnostics Centers
6.4.2.1. Market estimates and forecasts 2018 - 2030 (USD Million)
6.4.3. Others
6.4.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)
CHAPTER 7. U.S. DRIED BLOOD SPOT COLLECTION CARDS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
7.1. Regional Market Share, 2023 & 2030
7.2. Segment Dashboard
7.3. U.S. Dried Blood Spot Collection Cards Market by Regional Outlook
7.4. Market Size & Forecasts and Trend Analyses, 2018 - 2030 for the Following
7.4.1. West
7.4.1.1. Market estimates and forecasts 2018 - 2030 (USD Million)
7.4.2. Midwest
7.4.2.1. Market estimates and forecasts 2018 - 2030 (USD Million)
7.4.3. Northeast
7.4.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)
7.4.4. Southwest
7.4.4.1. Market estimates and forecasts 2018 - 2030 (USD Million)
7.4.5. Southeast
7.4.5.1. Market estimates and forecasts 2018 - 2030 (USD Million)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company heat map analysis, 2023
8.4. Company Profiles
8.4.1. Whatman plc (Cytiva)
8.4.1.1. Company overview
8.4.1.2. Financial performance
8.4.1.3. Product benchmarking
8.4.1.4. Strategic initiatives
8.4.2. GE Healthcare
8.4.2.1. Company overview
8.4.2.2. Financial performance
8.4.2.3. Product benchmarking
8.4.2.4. Strategic initiatives
8.4.3. MilliporeSigma
8.4.3.1. Company overview
8.4.3.2. Financial performance
8.4.3.3. Product benchmarking
8.4.3.4. Strategic initiatives
8.4.4. QIAGEN LLC
8.4.4.1. Company overview
8.4.4.2. Financial performance
8.4.4.3. Product benchmarking
8.4.4.4. Strategic initiatives
8.4.5. PerkinElmer
8.4.5.1. Company overview
8.4.5.2. Financial performance
8.4.5.3. Product benchmarking
8.4.5.4. Strategic initiatives
8.4.6. Roche
8.4.6.1. Company overview
8.4.6.2. Financial performance
8.4.6.3. Product benchmarking
8.4.6.4. Strategic initiatives
8.4.7. Shimadzu Corporation
8.4.7.1. Company overview
8.4.7.2. Financial performance
8.4.7.3. Product benchmarking
8.4.7.4. Strategic initiatives
8.4.8. Ahlstrom-Munksjц
8.4.8.1. Company overview
8.4.8.2. Financial performance
8.4.8.3. Product benchmarking
8.4.8.4. Strategic initiatives
8.4.9. Eastern Business Forms, Inc.
8.4.9.1. Company overview
8.4.9.2. Financial performance
8.4.9.3. Product benchmarking
8.4.9.4. Strategic initiatives
8.4.10. CENTOGENE N.V.
8.4.10.1. Company overview
8.4.10.2. Financial performance
8.4.10.3. Product benchmarking
8.4.10.4. Strategic initiatives
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Application
1.2.2. Card Type
1.2.3. End-use
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Volume price analysis (Model 2)
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Application outlook
2.2.2. Card Type outlook
2.2.3. End-use outlook
2.3. Competitive Insights
CHAPTER 3. U.S. DRIED BLOOD SPOT COLLECTION CARDS MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. U.S. Dried Blood Spot Collection Cards Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
CHAPTER 4. U.S. DRIED BLOOD SPOT COLLECTION CARDS MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
4.1. Application Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. U.S. Dried Blood Spot Collection Cards Market by Application Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4.1. Newborn Screening (NBS)
4.4.1.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.4.2. Infectious Diseases Testing
4.4.2.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.4.3. Therapeutic Drug Monitoring
4.4.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.4.4. Forensics
4.4.4.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.4.5. CRO/Research
4.4.5.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.4.6. Other Applications
4.4.6.1. Market estimates and forecasts 2018 - 2030 (USD Million)
CHAPTER 5. U.S. DRIED BLOOD SPOT COLLECTION CARDS MARKET: CARD TYPE ESTIMATES & TREND ANALYSIS
5.1. Card Type Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. U.S. Dried Blood Spot Collection Cards Market by Card Type Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4.1. Whatman
5.4.1.1. Market estimates and forecasts 2018 - 2030 (USD Million)
5.4.2. Ahlstrom
5.4.2.1. Market estimates and forecasts 2018 - 2030 (USD Million)
5.4.3. FTA
5.4.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)
5.4.4. Others
5.4.4.1. Market estimates and forecasts 2018 - 2030 (USD Million)
CHAPTER 6. U.S. DRIED BLOOD SPOT COLLECTION CARDS MARKET: END-USE ESTIMATES & TREND ANALYSIS
6.1. End-use Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. U.S. Dried Blood Spot Collection Cards Market by End-use Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.4.1. Hospitals & Clinics
6.4.1.1. Market estimates and forecasts 2018 - 2030 (USD Million)
6.4.2. Diagnostics Centers
6.4.2.1. Market estimates and forecasts 2018 - 2030 (USD Million)
6.4.3. Others
6.4.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)
CHAPTER 7. U.S. DRIED BLOOD SPOT COLLECTION CARDS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
7.1. Regional Market Share, 2023 & 2030
7.2. Segment Dashboard
7.3. U.S. Dried Blood Spot Collection Cards Market by Regional Outlook
7.4. Market Size & Forecasts and Trend Analyses, 2018 - 2030 for the Following
7.4.1. West
7.4.1.1. Market estimates and forecasts 2018 - 2030 (USD Million)
7.4.2. Midwest
7.4.2.1. Market estimates and forecasts 2018 - 2030 (USD Million)
7.4.3. Northeast
7.4.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)
7.4.4. Southwest
7.4.4.1. Market estimates and forecasts 2018 - 2030 (USD Million)
7.4.5. Southeast
7.4.5.1. Market estimates and forecasts 2018 - 2030 (USD Million)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company heat map analysis, 2023
8.4. Company Profiles
8.4.1. Whatman plc (Cytiva)
8.4.1.1. Company overview
8.4.1.2. Financial performance
8.4.1.3. Product benchmarking
8.4.1.4. Strategic initiatives
8.4.2. GE Healthcare
8.4.2.1. Company overview
8.4.2.2. Financial performance
8.4.2.3. Product benchmarking
8.4.2.4. Strategic initiatives
8.4.3. MilliporeSigma
8.4.3.1. Company overview
8.4.3.2. Financial performance
8.4.3.3. Product benchmarking
8.4.3.4. Strategic initiatives
8.4.4. QIAGEN LLC
8.4.4.1. Company overview
8.4.4.2. Financial performance
8.4.4.3. Product benchmarking
8.4.4.4. Strategic initiatives
8.4.5. PerkinElmer
8.4.5.1. Company overview
8.4.5.2. Financial performance
8.4.5.3. Product benchmarking
8.4.5.4. Strategic initiatives
8.4.6. Roche
8.4.6.1. Company overview
8.4.6.2. Financial performance
8.4.6.3. Product benchmarking
8.4.6.4. Strategic initiatives
8.4.7. Shimadzu Corporation
8.4.7.1. Company overview
8.4.7.2. Financial performance
8.4.7.3. Product benchmarking
8.4.7.4. Strategic initiatives
8.4.8. Ahlstrom-Munksjц
8.4.8.1. Company overview
8.4.8.2. Financial performance
8.4.8.3. Product benchmarking
8.4.8.4. Strategic initiatives
8.4.9. Eastern Business Forms, Inc.
8.4.9.1. Company overview
8.4.9.2. Financial performance
8.4.9.3. Product benchmarking
8.4.9.4. Strategic initiatives
8.4.10. CENTOGENE N.V.
8.4.10.1. Company overview
8.4.10.2. Financial performance
8.4.10.3. Product benchmarking
8.4.10.4. Strategic initiatives
LIST OF TABLES
Table 1 List of abbreviations
Table 2 U.S. Dried Blood Spot Collection Cards Market, by Application, 2018 - 2030 (USD Million)
Table 3 U.S. Dried Blood Spot Collection Cards Market, by Card Type, 2018 - 2030 (USD Million)
Table 4 U.S. Dried Blood Spot Collection Cards Market, by End-use, 2018 - 2030 (USD Million)
Table 5 U.S. Dried Blood Spot Collection Cards Market, by Region, 2018 - 2030 (USD Million)
Table 1 List of abbreviations
Table 2 U.S. Dried Blood Spot Collection Cards Market, by Application, 2018 - 2030 (USD Million)
Table 3 U.S. Dried Blood Spot Collection Cards Market, by Card Type, 2018 - 2030 (USD Million)
Table 4 U.S. Dried Blood Spot Collection Cards Market, by End-use, 2018 - 2030 (USD Million)
Table 5 U.S. Dried Blood Spot Collection Cards Market, by Region, 2018 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 U.S. dried blood spot collection cards market: market outlook
Fig. 9 U.S. dried blood spot collection cards competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 U.S. dried blood spot collection cards market driver impact
Fig. 14 U.S. dried blood spot collection cards market restraint impact
Fig. 15 U.S. dried blood spot collection cards market: Application movement analysis
Fig. 16 U.S. dried blood spot collection cards market: Application outlook and key takeaways
Fig. 17 Newborn screening (NBS) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 18 Infectious diseases testing estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 19 Therapeutic drug monitoring estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 Forensics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 CRO/research estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Other applications estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 U.S. dried blood spot collection cards market: Card type movement analysis
Fig. 24 U.S. dried blood spot collection cards market: Card type outlook and key takeaways
Fig. 25 Whatman 903 market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Ahlstrom 226 market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 FTA market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 U.S. dried blood spot collection cards market: End-use movement analysis
Fig. 30 U.S. dried blood spot collection cards market: End-use outlook and key takeaways
Fig. 31 Hospitals & clinics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 Diagnostics centers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 U.S. dried blood spot collection cards market: Regional movement analysis
Fig. 35 U.S. dried blood spot collection cards market: Regional outlook and key takeaways
Fig. 36 West market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Midwest market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Northeast market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Southwest market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Southeast market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 U.S. dried blood spot collection cards market: market outlook
Fig. 9 U.S. dried blood spot collection cards competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 U.S. dried blood spot collection cards market driver impact
Fig. 14 U.S. dried blood spot collection cards market restraint impact
Fig. 15 U.S. dried blood spot collection cards market: Application movement analysis
Fig. 16 U.S. dried blood spot collection cards market: Application outlook and key takeaways
Fig. 17 Newborn screening (NBS) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 18 Infectious diseases testing estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 19 Therapeutic drug monitoring estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 Forensics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 CRO/research estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Other applications estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 U.S. dried blood spot collection cards market: Card type movement analysis
Fig. 24 U.S. dried blood spot collection cards market: Card type outlook and key takeaways
Fig. 25 Whatman 903 market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Ahlstrom 226 market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 FTA market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 U.S. dried blood spot collection cards market: End-use movement analysis
Fig. 30 U.S. dried blood spot collection cards market: End-use outlook and key takeaways
Fig. 31 Hospitals & clinics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 Diagnostics centers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 U.S. dried blood spot collection cards market: Regional movement analysis
Fig. 35 U.S. dried blood spot collection cards market: Regional outlook and key takeaways
Fig. 36 West market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Midwest market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Northeast market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Southwest market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Southeast market estimates and forecasts, 2018 - 2030 (USD Million)
